Hanmi Pharmaceutical R&D investment 2017-2019

This statistic presents the investment in research and development of the South Korean company Hanmi Pharmaceutical Co., Ltd. from 2017 to 2019. In 2019, the company's R&D investment amounted to around 178 billion South Korean won, up from almost 160 billion won in 2018.

Investment in research and development of Hanmi Pharmaceutical Co., Ltd. from 2017 to 2019 (in billion South Korean won)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

South Korea

Survey time period

2017 to 2019

Supplementary notes

* Hanmi Pharmaceutical Co., Ltd. is a subsidiary of the holding company Hanmi Science Co., Ltd.
Note: 1,000 South Korean won equal 0.84 U.S. dollars and 0.71 euros (as of August 2020).
Figures have been rounded.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.